156 related articles for article (PubMed ID: 20573874)
1. Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance.
Jang H; Kim J; Choi JJ; Son Y; Park H
J Clin Microbiol; 2010 Sep; 48(9):3127-31. PubMed ID: 20573874
[TBL] [Abstract][Full Text] [Related]
2. Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
Xu Z; Liu Y; Xu T; Chen L; Si L; Wang Y; Ren X; Zhong Y; Zhao J; Xu D
J Clin Virol; 2010 Aug; 48(4):270-4. PubMed ID: 20580309
[TBL] [Abstract][Full Text] [Related]
3. Detection of lamivudine- or adefovir-resistant hepatitis B virus mutations by a liquid array.
Liu H; Mao R; Fan L; Xia J; Li Y; Yin Y; Li X; Zhao X; Guo H; Zhu H; Zhang Y; Kang Y; Zhang J
J Virol Methods; 2011 Jul; 175(1):1-6. PubMed ID: 21513743
[TBL] [Abstract][Full Text] [Related]
4. Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay.
Tadokoro K; Suzuki F; Kobayashi M; Yamaguchi T; Nagano M; Egashira T; Kumada H
J Virol Methods; 2011 Jan; 171(1):67-73. PubMed ID: 20950650
[TBL] [Abstract][Full Text] [Related]
5. Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir.
Hussain M; Fung S; Libbrecht E; Sablon E; Cursaro C; Andreone P; Lok AS
J Clin Microbiol; 2006 Mar; 44(3):1094-7. PubMed ID: 16517902
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of peptide nucleic acid array for the detection of hepatitis B virus mutations associated with antiviral resistance.
Choi YJ; Kim HS; Lee SH; Park JS; Nam HS; Kim HJ; Kim CJ; Jeong DJ; Park KS; Baek KA
Arch Virol; 2011 Sep; 156(9):1517-24. PubMed ID: 21594598
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus rtA181T/sW172non-stop mutation may increase resistance fold to adefovir- and entecavir-resistant mutants compared to rtA181T/sW172* mutation.
Zhao L; Li X; Cheng Y; Chen R; Shao J; Zhou Y; Li Q; Liao H; Zhao Y; Liu L; Su H; Liu Y; Liu Y; Xu D
Antiviral Res; 2018 Jun; 154():26-34. PubMed ID: 29630974
[TBL] [Abstract][Full Text] [Related]
8. An improved reverse dot hybridization for simple and rapid detection of adefovir dipivoxil-resistant hepatitis B virus.
Hu Y; Zhang WL; Xie SL; Zhao Y; Hu JL; Cai XF; Lai GQ; Huang AL
Genet Mol Res; 2012 Jan; 11(1):53-60. PubMed ID: 22290465
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B.
Su F; Dai J; Yang S; Jiang X; Cui X; Ning H; Li J; Huang M
J Med Virol; 2015 Sep; 87(9):1527-31. PubMed ID: 26032700
[TBL] [Abstract][Full Text] [Related]
10. Analysis of HBV genotype, drug resistant mutations, and pre-core/basal core promoter mutations in Korean patients with acute hepatitis B.
Lee JH; Hong SP; Jang ES; Park SJ; Hwang SG; Kang SK; Jeong SH
J Med Virol; 2015 Jun; 87(6):993-8. PubMed ID: 25712861
[TBL] [Abstract][Full Text] [Related]
11. Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).
Osiowy C; Villeneuve JP; Heathcote EJ; Giles E; Borlang J
J Clin Microbiol; 2006 Jun; 44(6):1994-7. PubMed ID: 16757589
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous detection of hepatitis B virus genotypes and mutations associated with resistance to lamivudine, adefovir, and telbivudine by the polymerase chain reaction-ligase detection reaction.
Wang YZ; Xiao JH; Liu LG; Ye CY; Shen HY; Xu TM; Zhu KZ
Braz J Infect Dis; 2011; 15(6):560-6. PubMed ID: 22218515
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
14. Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity.
Ogata N; Ichida T; Aoyagi Y; Kitajima I
Rinsho Byori; 2003 Apr; 51(4):313-9. PubMed ID: 12747252
[TBL] [Abstract][Full Text] [Related]
15. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
Neumann-Fraune M; Beggel B; Pfister H; Kaiser R; Verheyen J
J Med Virol; 2013 May; 85(5):775-9. PubMed ID: 23408582
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir.
Zaaijer HL; Takkenberg RB; Weegink CJ; Rebers SP; Menting S; Reesink HW; Schinkel J; Molenkamp R
J Med Virol; 2009 Mar; 81(3):413-6. PubMed ID: 19152408
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.
Degertekin B; Hussain M; Tan J; Oberhelman K; Lok AS
J Hepatol; 2009 Jan; 50(1):42-8. PubMed ID: 19019484
[TBL] [Abstract][Full Text] [Related]
18. Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.
Cha CK; Kwon HC; Cheong JY; Cho SW; Hong SP; Kim SO; Yoo WD
J Med Virol; 2009 Mar; 81(3):417-24. PubMed ID: 19152409
[TBL] [Abstract][Full Text] [Related]
19. Assessment of selective real-time PCR for quantitation of lamivudine and adefovir hepatitis B virus-resistant strains and comparison with direct sequencing and line probe assays.
Lupo J; Larrat S; Hilleret MN; Germi R; Boyer V; Nicod S; Barguès G; Leroy V; Seigneurin JM; Zarski JP; Morand P
J Virol Methods; 2009 Mar; 156(1-2):52-8. PubMed ID: 19041345
[TBL] [Abstract][Full Text] [Related]
20. [Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year].
Aydoğan S; Ergünay K; Balaban Y; Alp A; Simşek H; Tatar G; Hasçelik G; Us D
Mikrobiyol Bul; 2013 Jul; 47(3):472-81. PubMed ID: 23971924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
